Cantor Fitzgerald Reaffirms Overweight Rating for Aurora Innovation (NASDAQ:AUR)
Aurora Innovation (NASDAQ:AUR – Get Free Report)‘s stock had its “overweight” rating reiterated by equities researchers at ...
Equities Analysts Issue Forecasts for Biogen FY2025 Earnings
Equities research analysts at Cantor Fitzgerald decreased their FY2025 earnings estimates for Biogen in a research note ...
Phathom spikes as Cantor Fitzgerald bullish on IP claims
Phathom Pharmaceuticals (NASDAQ:PHAT) traded higher on Friday after Cantor Fitzgerald initiated its coverage with an overweight recommendation despite a recent selloff attributed to the company's IP ...
Cantor Fitzgerald maintains $118 target on Ultragenyx stock
Cantor Fitzgerald reaffirmed its Overweight rating and $118.00 price target for Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company specializing in rare diseases. Currently ...
El País in English11h
Wrestling, cannabis, bitcoin and stocks: This is how Trump’s government of billionaires invests
Although Elon Musk attracts most of the headlines, the US Cabinet is full of other wealthy individuals who have significant ...
Finbold | Finance in Bold22h
Why Lucid stock is surging
Lucid stock saw a 14.03% move to the upside on February 13 after an eminent Wall Street firm initiated coverage with a $5 ...